Osteopontin

Osteopontin (OPN) is a secreted, multifunctional, extracellular matrix (ECM), calcium-binding, glycosylated phosphoprotein that is associated with various normal biological functions and pathological processes. OPN is physiologically produced by a wide range of cells and has been identified in various body fluids, playing a crucial role in bone remodeling and vascularization. OPN is also expressed by multiple immune cells, acting as a chemotactic factor, a mediator of cell activation and cytokine production, and an anti-apoptotic factor, thereby regulating inflammation and immune responses. OPN can be involved in the tumorigenesis of various cancer types, including head and neck squamous cell carcinoma (HNSCC), by promoting cell proliferation, adhesion, invasion, and migration through multiple signaling pathways[1][2].

共 3种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Anti-Mouse osteopontin/SPP1 Antibody (100D3)

Anti-Mouse osteopontin/SPP1 Antibody (100D3) 是一种抗小鼠 osteopontin/SPP1 的 IgG2c 单克隆抗体,可逆转骨桥蛋白 (OPN) 对 T 细胞的抑制作用并增强细胞毒性 T 淋巴细胞 (CTL) 的杀伤能力,还能提高牙本质密度,可用于研究癌症和牙齿相关疾病(如结肠癌),其同型对照为 Mouse IgG2c kappa, Isotype Control (MS-J64914)。

Inhibitor
95%
Anti-Mouse osteopontin/SPP1 Antibody (100D3)
Anti-Mouse osteopontin/SPP1 Antibody (103D6)

Anti-Mouse osteopontin/SPP1 Antibody (103D6) 是一种源自小鼠的抗小鼠 osteopontin/SPP1 IgG2c κ 型抗体抑制剂,可增强细胞毒性 T 淋巴细胞的裂解活性并抑制结肠肿瘤生长,还能改善胆总管结扎 (CBDL) 诱导的原发性硬化性胆管炎模型小鼠的肝损伤。

Inhibitor
99.76%
Anti-Mouse osteopontin/SPP1 Antibody (103D6)
OPN-IN-1

OPN-IN-1 是一种骨桥蛋白 (OPN) 表达抑制剂,具有潜在的抗乳腺癌细胞转移活性,可用于肿瘤研究。

2257492-95-6
Inhibitor
99.98%
OPN-IN-1

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础